ATE128733T1 - Monoklonale antikörper gegen hiv gp120. - Google Patents
Monoklonale antikörper gegen hiv gp120.Info
- Publication number
- ATE128733T1 ATE128733T1 AT91109937T AT91109937T ATE128733T1 AT E128733 T1 ATE128733 T1 AT E128733T1 AT 91109937 T AT91109937 T AT 91109937T AT 91109937 T AT91109937 T AT 91109937T AT E128733 T1 ATE128733 T1 AT E128733T1
- Authority
- AT
- Austria
- Prior art keywords
- monoclonal antibodies
- antibodies against
- against hiv
- antibodies
- amino acid
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000004408 hybridoma Anatomy 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54002590A | 1990-06-18 | 1990-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE128733T1 true ATE128733T1 (de) | 1995-10-15 |
Family
ID=24153675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91109937T ATE128733T1 (de) | 1990-06-18 | 1991-06-18 | Monoklonale antikörper gegen hiv gp120. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0462551B1 (de) |
JP (1) | JPH04299993A (de) |
KR (1) | KR920000333A (de) |
AT (1) | ATE128733T1 (de) |
AU (1) | AU651113B2 (de) |
CA (1) | CA2044741A1 (de) |
DE (1) | DE69113520T2 (de) |
DK (1) | DK0462551T3 (de) |
ES (1) | ES2080193T3 (de) |
GR (1) | GR3018082T3 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP237A (en) * | 1990-05-29 | 1993-04-29 | Cedars Sinai Medical Center | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use. |
EP0554401A4 (en) * | 1990-10-26 | 1996-10-30 | New York Health Res Inst | Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
US5556744A (en) * | 1992-05-29 | 1996-09-17 | The Trustees Of The University Of Pennsylvania | Methods and compositions for diagnosing and treating certain HIV infected patients |
CN115379856A (zh) * | 2019-10-29 | 2022-11-22 | 国际艾滋病疫苗行动组织 | HIV Env的工程化抗体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0511967B1 (de) * | 1990-01-26 | 1996-02-28 | Bay Development Corporation Sa | Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern |
-
1991
- 1991-06-17 CA CA002044741A patent/CA2044741A1/en not_active Abandoned
- 1991-06-17 KR KR1019910009944A patent/KR920000333A/ko not_active Application Discontinuation
- 1991-06-17 AU AU78475/91A patent/AU651113B2/en not_active Ceased
- 1991-06-18 ES ES91109937T patent/ES2080193T3/es not_active Expired - Lifetime
- 1991-06-18 EP EP91109937A patent/EP0462551B1/de not_active Revoked
- 1991-06-18 DE DE69113520T patent/DE69113520T2/de not_active Revoked
- 1991-06-18 AT AT91109937T patent/ATE128733T1/de not_active IP Right Cessation
- 1991-06-18 DK DK91109937.2T patent/DK0462551T3/da active
- 1991-06-18 JP JP3145781A patent/JPH04299993A/ja active Pending
-
1995
- 1995-11-15 GR GR950403200T patent/GR3018082T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2080193T3 (es) | 1996-02-01 |
DK0462551T3 (da) | 1996-02-12 |
DE69113520D1 (de) | 1995-11-09 |
AU651113B2 (en) | 1994-07-14 |
DE69113520T2 (de) | 1996-05-09 |
KR920000333A (ko) | 1992-01-29 |
EP0462551B1 (de) | 1995-10-04 |
AU7847591A (en) | 1991-12-19 |
CA2044741A1 (en) | 1991-12-19 |
JPH04299993A (ja) | 1992-10-23 |
GR3018082T3 (en) | 1996-02-29 |
EP0462551A1 (de) | 1991-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0690132T3 (da) | Monoklonalt anti-HIV-antistof | |
TR199900722T2 (xx) | Yeniden kurulmu� insan anti-HM1.24 antikoru. | |
ATE405679T1 (de) | Synthetische humane neutralisierende monoklonale antikörper gegen hiv | |
DE69838454D1 (de) | Natürlicher menschlicher antikörper | |
EP0675904A4 (de) | Humane neutralisierende monoklonale antikörper gegen den die immunschwäche auslösenden virus aus mensch. | |
CA2091263A1 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
ES2046510T3 (es) | Procedimiento de preparacion de polimeros yodados. | |
ATE159983T1 (de) | Monoklonaler antikörper gegen htlv-iii (stamm mn) | |
ATE128733T1 (de) | Monoklonale antikörper gegen hiv gp120. | |
DE69213325D1 (de) | Gegen das menschliche Immunschwäche-Virus gerichtetes Immunpräparat | |
DK0585570T3 (da) | Granulocytbindende antistofkonstrukter, deres fremstilling og anvendelse | |
DK373489D0 (da) | Rekombinante hybrid-partikler med morphologiske egenskaber svarende til antigenet hbsag og omfattende en immunogen sekvens, der inducerer neutraliserende antistoffer rettet mod hiv-retrovirus eller som kan genkendes af saadanne antistoffer, samt vaccine paa basis af saadanne partikler | |
GR3024670T3 (en) | Induction of protection against viral infection | |
DK0732339T3 (da) | Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf | |
DE68926454D1 (de) | Gegen hiv 1 gp48 spezifische antikörper | |
AU627540B2 (en) | Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof | |
FR2646607B1 (fr) | Anticorps monoclonaux anti-b2 microglobuline | |
MX9602981A (es) | Solucion inyectable de floruro de benzalconio. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
RZN | Patent revoked |